Intratype sequence variation among clinical isolates of the human papillomavirus type 6 L1 ORF: clustering of mutations and identification of a frequent amino acid sequence variant. Free

Abstract

Human papillomavirus type 6 (HPV-6) is the causative agent of condyloma acuminata, a common sexually transmitted disease. Virus-like particles (VLPs) assembled from the L1 major capsid protein represent promising candidates for prophylactic vaccines. However, any intratype sequence variation among HPV-6 L1 ORFs will influence which sequence is used for a vaccine according to its prevalence in the population and its propensity for VLP production. Therefore, we have analysed the entire L1 nucleotide sequence of 17 clinical isolates of HPV-6 from the London area. We found 28 positions where changes from the prototype HPV-6b L1 occurred, showing that HPV-6 L1 intratype variation is greater than previously reported. The most frequently observed substitutions are clustered into three discrete regions: R1 (nt 5920-6075), R2 (nt 6590-6670) and R3 (nt 7070-7230). Indeed, most of the nucleotide substitutions within the HPV-6 L1 reported worldwide also map to these regions. The R3 region contains predominantly non-silent substitutions, the most common of which is a G-to-C substitution at position 7079. This results in a Glu-to-Gln change at aa 431, although this change had no effect on VLP yield or stability. This substitution defines a new HPV-6 L1 amino acid sequence that is more abundant in the isolates examined than any other reported sequence.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-4-1025
1999-04-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/4/0801025a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-4-1025&mimeType=html&fmt=ahah

References

  1. Alvarez I. A., Lazo P. S., Gonzalez S. R., Tapia J. P. R., Batalla F. N., Nieto C. S. 1997; Using polymerase chain reaction to human papillomavirus in oral and pharyngolaryngeal carcinomas. American Journal of Otolaryngology 18:375–381
    [Google Scholar]
  2. Becker D. M., Guarente L. 1991; High efficiency transformation of yeast cells by electroporation. Methods in Enzymology 194:182–187
    [Google Scholar]
  3. Bercovich J. A., Centeno C. R., Aguilar O. G., Grinstein S., Kahn T. 1991; Presence and integration of human papillomavirus type 6 in a tonsillar carcinoma. Journal of General Virology 72:2569–2572
    [Google Scholar]
  4. Breitburd F., Kirnbauer R., Hubbert N. L., Nonnenmacher B., Trin-Dihn-Desmarquet C., Orth G., Schiller J. T., Lowy D. R. 1995; Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. Journal of Virology 69:3959–3963
    [Google Scholar]
  5. Burnette W. N. 1981; Western blotting: electrophoretic transfer of proteins from SDS-polyacrylamide gels to nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Annals of Biochemistry 112:195–203
    [Google Scholar]
  6. Chan S. Y., Delius H., Halpern A. L., Bernard H. U. 1995; Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny and taxonomy. Journal of Virology 69:3074–3083
    [Google Scholar]
  7. Cullen A. P., Reid R., Campion M., Lörincz A. T. 1991; Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. Journal ofVirology 65:606–612
    [Google Scholar]
  8. De Villiers E. M. 1989; Heterogeneity of the human papillomavirus group. Journal of Virology 63:4898–4903
    [Google Scholar]
  9. Grassmann K., Wilczynski S. P., Cook N. P., Rapp B., Iftner T. 1996; HPV6 variants from malignant tumors with sequence alterations in the regulatory region do not reveal differences in the activities of the oncogene promoters but do contain amino acid changes in the E6 and E7 proteins. Virology 223:185–197
    [Google Scholar]
  10. Hagensee M. E., Olson N. H., Baker T. S., Galloway D. A. 1994; Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids. Journal of Virology 68:4503–4505
    [Google Scholar]
  11. Heino P., Dillner J., Schwartz S. 1995; Human papillomavirus type 16 capsid proteins produced from recombinant Semliki forest virus assemble into virus-like particles. Virology 214:349–359
    [Google Scholar]
  12. Heinzel P. A., Chan S.-Y., Ho L., O’Connor M., Balaram P., Campo S. M., Fujinaga K., Kiviat N., Kuypers J., Pfister H., Steinberg B. M., Tay S.-K., Villa L. L., Bernard H.-U. 1995; Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. Journal of Clinical Microbiology 33:1746–1754
    [Google Scholar]
  13. Hofmann K. J., Cook J. C., Joyce J. G., Brown D. R., Schultz L. D., George H. A., Rosolowsky M., Fife K. H., Jansen K. U. 1995; Sequence determination of human papillomavirus type 6a and assembly of virus like particles in Saccharomyces cerevisiae . Virology 209:506–518
    [Google Scholar]
  14. Icenogle J. P., Sathya P., Miller D. L., Tucker R. A., Rawls W. E. 1991; Nucleotide and amino acid sequence variation in the L1 and E7 open reading frames of human papillomavirus type 6 and type 16. Virology 194:101–107
    [Google Scholar]
  15. Kirnbauer R., Booy F., Cheng N., Lowy D. R., Schiller J. T. 1992; Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proceedings of the National Academy of Sciences, USA 89:12180–12184
    [Google Scholar]
  16. Kirnbauer R., Chandrachud L. M., O’Neil B. W., Wagner E. R., Grindlay G. J., Armstrong A., McGarvie G. M., Schiller J. T., Lowy D. R., Campo M. S. 1996; Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. Virology 219:37–44
    [Google Scholar]
  17. McLean C. S., Churcher M. J., Meinke J., Smith G. L., Higgins G., Stanley M., Minson A. C. 1990; Production and characterization of a monoclonal antibody to human papillomavirus type 16 using a recombinant vaccinia virus. Journal of Clinical Pathology 43:488–492
    [Google Scholar]
  18. Roman A., Brown D. 1995; Sequence variation in the extreme 5′ end of the human papillomavirus type 6a long control region. Journal of Infectious Diseases 171:697–700
    [Google Scholar]
  19. Rübben A., Beaudenon S., Favre M., Schmitz W., Spelten B., Grussendorf-Conen E.-I. 1992; Rearrangements of the upstream regulatory region of human papillomavirus type 6 can be found in both Buschke-Lowenstein tumours and in condylomata acuminata. Journal of General Virology 73:3147–3153
    [Google Scholar]
  20. Sasagawa T., Pushko P., Steers G., Gscheimer S. E., Hajibagheri M. A. N., Finch J., Crawford L., Tomassino M. 1995; Synthesis and assembly of virus-like particles of human papillomavirus type 6 and type 16 in fission yeast Schizosaccharomyces pombe . Virology 206:126–135
    [Google Scholar]
  21. Schneider J. C., Guarente L. 1991; Vectors for expression of cloned genes in yeast: regulation, overproduction and underproduction. Methods in Enzymology 194:373–388
    [Google Scholar]
  22. Schwarz E., Durst M., Demnkowski C., Latterman O., Zech R., Wolfsperger E., Suhai S., zur Hausen H. 1983; DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO Journal 2:2341–2348
    [Google Scholar]
  23. Stewart A. C., Eriksson A. M., Manos M. M., Muñoz N., Bosch F. X., Peto J., Wheeler C. M. 1996; Intratype variation in human papillomavirus types: a worldwide perspective. Journal of Virology 70:3127–3136
    [Google Scholar]
  24. Suzuki T., Tomita Y., Nakano K., Shirasawa H., Simizu B. 1995; Deletion in the L1 open reading frame of human papillomavirus type 6a genomes associated with recurrent laryngeal papilloma. Journal ofMedical Virology 47:191–197
    [Google Scholar]
  25. Suzuki T., Tomita Y., Nagata H., Kono A., Simizu B. 1997; Nucleotide and amino acid sequence variations in the L1 open reading frame of human papillomavirus type 6. Journal of Medical Virology 53:19–24
    [Google Scholar]
  26. Touze A., El Mehdahoui S., Sizaret P.-Y., Mougin C., Munoz N., Coursaget P. 1998; The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system. Journal of Clinical Microbiology 362046–2051
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-4-1025
Loading
/content/journal/jgv/10.1099/0022-1317-80-4-1025
Loading

Data & Media loading...

Most cited Most Cited RSS feed